Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study.

Laguno, M

Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study. [electronic resource] - International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases Dec 2016 - 46-51 p. digital

Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study

1878-3511

10.1016/j.ijid.2016.10.028 doi


Adult
Antiviral Agents--therapeutic use
Coinfection
Drug Therapy, Combination
Female
Genotype
HIV Infections--complications
Hepacivirus--drug effects
Hepatitis C--complications
Humans
Interferon-alpha--therapeutic use
Male
Middle Aged
Polyethylene Glycols--therapeutic use
Proline--analogs & derivatives
Prospective Studies
Recombinant Proteins--therapeutic use
Retreatment
Ribavirin--therapeutic use
Spain
Treatment Outcome
Viral Nonstructural Proteins--antagonists & inhibitors